Arbutus Biopharma Corporation (ABUS) SEC filings
ABUS SEC filings moved a median of +0.40% by the close. ABUS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ABUS overview →
67 measured ABUS SEC filing events.
Where these ABUS SEC filings landedvs 65 measured ABUS SEC filing reactions
| Middle 50% of ABUS SEC filing reactions | -1.61% to +2.21% |
|---|---|
| Median reaction (to close) | +0.40% |
| Measured reactions | 65 |
Point-in-time · zero look-ahead
Half of the 65 ABUS SEC filing events with a measured close landed between -1.61% and +2.21%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Arbutus Biopharma Corp For: Aug 21 | SEC filing · Form 8-K | +2.88% | +0.19% | |
| Form 10-Q Arbutus Biopharma Corp For: Jun 30 | SEC filing · Form 10-Q | -2.20% | +0.00% | |
| Form 8-K Arbutus Biopharma Corp For: Aug 12 | SEC filing · Form 8-K | -2.20% | +0.00% | |
| Form 8-K Arbutus Biopharma Corp For: Jul 15 | SEC filing · Form 8-K | -1.90% | +0.00% | |
| Form S-8 Arbutus Biopharma Corp | SEC filing · Form S-8 | -0.23% | -0.94% | |
| Form 8-K Arbutus Biopharma Corp For: May 26 | SEC filing · Form 8-K | -0.43% | -0.43% | |
| Form 10-Q Arbutus Biopharma Corp For: Mar 31 | SEC filing · Form 10-Q | -1.45% | -4.01% | |
| Form 8-K Arbutus Biopharma Corp For: May 13 | SEC filing · Form 8-K | -1.45% | -4.01% | |
| Form 8-K Arbutus Biopharma Corp For: Apr 14 | SEC filing · Form 8-K | -0.44% | -1.75% | |
| Form DEF 14A Arbutus Biopharma Corp For: May 26 | SEC filing · Form DEF | -0.44% | -1.75% | |
| Form DEFA14A Arbutus Biopharma Corp | SEC filing · Form DEFA14A | -0.44% | -1.75% | |
| Form 10-K Arbutus Biopharma Corp For: Dec 31 | SEC filing · Form 10-K | +0.00% | +1.38% | |
| Form 8-K Arbutus Biopharma Corp For: Mar 23 | SEC filing · Form 8-K | +0.00% | +1.38% | |
| Form 8-K Arbutus Biopharma Corp For: Mar 03 | SEC filing · Form 8-K | +0.86% | +2.15% | |
| Form 8-K Arbutus Biopharma Corp For: Feb 17 | SEC filing · Form 8-K | +1.79% | +4.52% | |
| Form 8-K Arbutus Biopharma Corp For: Feb 02 | SEC filing · Form 8-K | -0.78% | +5.47% | |
| Form 8-K Arbutus Biopharma Corp For: Jan 15 | SEC filing · Form 8-K | -4.94% | +2.79% | |
| Form 8-K Arbutus Biopharma Corp For: Dec 11 | SEC filing · Form 8-K | +0.00% | +0.86% | |
| Form 10-Q Arbutus Biopharma Corp For: Sep 30 | SEC filing · Form 10-Q | -1.88% | — | |
| Form 8-K Arbutus Biopharma Corp For: Nov 13 | SEC filing · Form 8-K | -1.88% | — | |
| Form 8-K Arbutus Biopharma Corp For: Oct 07 | SEC filing · Form 8-K | +1.15% | -1.15% | |
| Form 8-K Arbutus Biopharma Corp For: Sep 09 | SEC filing · Form 8-K | +2.48% | +4.05% | |
| Form 10-Q Arbutus Biopharma Corp For: Jun 30 | SEC filing · Form 10-Q | -2.91% | +0.87% | |
| Form 8-K Arbutus Biopharma Corp For: Aug 04 | SEC filing · Form 8-K | -2.91% | +0.87% | |
| Form 8-K Arbutus Biopharma Corp For: Jun 20 | SEC filing · Form 8-K | +0.54% | -0.59% | |
| Form 8-K Arbutus Biopharma Corp For: May 21 | SEC filing · Form 8-K | +0.31% | +6.48% | |
| Form 10-Q Arbutus Biopharma Corp For: Mar 31 | SEC filing · Form 10-Q | -5.43% | -0.32% | |
| Form 8-K Arbutus Biopharma Corp For: May 14 | SEC filing · Form 8-K | +0.00% | +0.32% | |
| Form 8-K Arbutus Biopharma Corp For: May 07 | SEC filing · Form 8-K | -1.77% | -2.95% | |
| Form 8-K Arbutus Biopharma Corp For: Apr 23 | SEC filing · Form 8-K | +0.31% | -0.92% | |
| Form DEF 14A Arbutus Biopharma Corp For: May 21 | SEC filing · Form DEF | -4.14% | -4.30% | |
| Form DEFA14A Arbutus Biopharma Corp | SEC filing · Form DEFA14A | -4.14% | -4.30% | |
| Form 8-K Arbutus Biopharma Corp For: Mar 28 | SEC filing · Form 8-K | +0.29% | -5.28% | |
| Form 10-K Arbutus Biopharma Corp For: Dec 31 | SEC filing · Form 10-K | +0.27% | -2.39% | |
| Form 8-K Arbutus Biopharma Corp For: Mar 27 | SEC filing · Form 8-K | +0.27% | -2.39% | |
| Form 8-K Arbutus Biopharma Corp For: Mar 03 | SEC filing · Form 8-K | +0.99% | -0.29% | |
| Form 8-K Arbutus Biopharma Corp For: Feb 24 | SEC filing · Form 8-K | +7.94% | +1.47% | |
| Form 8-K Arbutus Biopharma Corp For: Jan 13 | SEC filing · Form 8-K | -1.85% | +3.08% | |
| Form EFFECT Arbutus Biopharma Corp | SEC filing · Form EFFECT | -0.14% | +1.38% | |
| Form 8-K Arbutus Biopharma Corp For: Nov 15 | SEC filing · Form 8-K | +0.86% | +4.75% | |
| Form 10-Q Arbutus Biopharma Corp For: Sep 30 | SEC filing · Form 10-Q | -1.53% | -4.85% | |
| Form 8-K Arbutus Biopharma Corp For: Nov 06 | SEC filing · Form 8-K | -2.09% | +1.82% | |
| Form S-3 Arbutus Biopharma Corp | SEC filing · Form S-3 | -1.53% | -4.85% | |
| Form 8-K Arbutus Biopharma Corp For: Oct 15 | SEC filing · Form 8-K | +0.13% | +5.12% | |
| Form 8-K Arbutus Biopharma Corp For: Oct 11 | SEC filing · Form 8-K | -0.13% | -0.52% | |
| Form 10-Q Arbutus Biopharma Corp For: Jun 30 | SEC filing · Form 10-Q | -0.14% | +1.11% | |
| Form S-8 Arbutus Biopharma Corp | SEC filing · Form S-8 | -0.14% | +1.11% | |
| Form 8-K Arbutus Biopharma Corp For: Aug 05 | SEC filing · Form 8-K | -1.12% | +1.40% | |
| Form 8-K Arbutus Biopharma Corp For: Aug 01 | SEC filing · Form 8-K | -6.59% | +4.67% | |
| Form 8-K Arbutus Biopharma Corp For: Jun 06 | SEC filing · Form 8-K | -0.86% | -4.16% | |
| Form 8-K Arbutus Biopharma Corp For: Jun 05 | SEC filing · Form 8-K | +0.15% | +7.40% | |
| Form 8-K Arbutus Biopharma Corp For: May 22 | SEC filing · Form 8-K | +0.01% | +1.82% | |
| Form 8-K Arbutus Biopharma Corp For: May 22 | SEC filing · Form 8-K | +2.17% | +5.90% | |
| Form 10-Q Arbutus Biopharma Corp For: Mar 31 | SEC filing · Form 10-Q | +1.48% | +0.00% | |
| Form 8-K Arbutus Biopharma Corp For: May 01 | SEC filing · Form 8-K | +0.00% | +1.51% | |
| Form 8-K Arbutus Biopharma Corp For: May 02 | SEC filing · Form 8-K | +0.00% | +1.51% | |
| Form DEF 14A Arbutus Biopharma Corp For: May 22 | SEC filing · Form DEF | +1.02% | +2.71% | |
| Form DEFA14A Arbutus Biopharma Corp | SEC filing · Form DEFA14A | +1.02% | +2.71% | |
| Form 8-K Arbutus Biopharma Corp For: Apr 04 | SEC filing · Form 8-K | +3.41% | +2.39% | |
| Form 10-K Arbutus Biopharma Corp For: Dec 31 | SEC filing · Form 10-K | +0.76% | +4.58% | |
| Form 8-K Arbutus Biopharma Corp For: Feb 29 | SEC filing · Form 8-K | -2.09% | -2.44% | |
| Form 8-K Arbutus Biopharma Corp For: Jan 08 | SEC filing · Form 8-K | -3.21% | -1.61% | |
| Form 8-K Arbutus Biopharma Corp For: Dec 31 | SEC filing · Form 8-K | -2.04% | +0.40% | |
| Form 8-K Arbutus Biopharma Corp For: Nov 09 | SEC filing · Form 8-K | -0.55% | -3.28% | |
| Form 10-Q Arbutus Biopharma Corp For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Arbutus Biopharma Corp For: Nov 01 | SEC filing · Form 8-K | -2.21% | +2.21% | |
| Form 8-K Arbutus Biopharma Corp For: Nov 07 | SEC filing · Form 8-K | -2.21% | +2.21% |
Keep exploring
More ABUS: earnings → · analyst actions → · ABUS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kezar Life Sciences, Inc. (KZR) | 192 | +0.14% | 55% |
| TAKEDA PHARMA (TKPYY) | 192 | 0.00% | 47% |
| BeiGene, Ltd. - American Depositary Shares (BGNE) | 191 | +0.11% | 52% |
| CYTODYN INC (CYDY) | 191 | -0.07% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.